Nalaganje...
INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES
Much attention has been recently paid to the study of interleukin 6 (IL-6) among the cytokines involved in the development of immune inflammatory rheumatic diseases (IIRDs). The introduction of monoclonal antibodies that inhibit the activity of IL-6 (tocilizumab, TCZ) in clinical practice in 2010 is...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IMA-PRESS LLC
2018-01-01
|
| Serija: | Научно-практическая ревматология |
| Teme: | |
| Online dostop: | https://rsp.mediar-press.net/rsp/article/view/2461 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|